Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2215512120Source: DataRank Database

The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance is a research paper published in Proceedings of the National Academy of Sciences (2023). On theSindex it has a DataRank of 0. It has been cited 29 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access29 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)OA: hybridTopics (29)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Kristin N. Adams,Feilin Nie,Elaine Fowler ORCID,Amit Kumar Verma ORCID,Silvia Dei ORCID

Live enrichment

PubMed:36763530 PMC:PMC7614234

Wellcome Trust

Grant: 211145/Z/18/Z

NIAID NIH HHS

Grant: R01 AI054503

NIAID NIH HHS

Grant: R01 AI150826

Wellcome Trust

Grant: 223103/Z/21/Z

NIAID NIH HHS

Grant: R37 AI054503

NIAID NIH HHS

Grant: U19 AI135976

NIAID NIH HHS

Grant: U19 AI162598

Wellcome Trust

Grant: 223103

Innate immunity and inflammation in tuberculosis: insights from the zebrafish and therapeutic opportunities

NIAID NIH HHS

Grant: R01 AI146194

Wellcome Trust

Grant: 211145

Mycobacterial Determinants of Extracellular Success

National Institutes of Health

Grant: 5R37AI054503-16

Host responses to Mycobacterium infection in Zebrafish.

hybridLicense: cc-by

publisherhttps://doi.org/10.1073/pnas.2215512120

repositoryhttps://flore.unifi.it/bitstream/2158/1299903/1/pnas.2215512120.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7614234

Europe_PMChttps://europepmc.org/articles/PMC7614234

Europe_PMChttps://europepmc.org/articles/PMC7614234?pdf=render

Fields of Study

0301 basic medicine03 medical and health sciences

MeSH Terms

MacrophagesHumansMycobacterium tuberculosisTuberculosisVerapamilRifampinBacterial ProteinsAntitubercular AgentsMicrobial Sensitivity TestsDrug ToleranceProton Pump Inhibitors

Keywords

VerapamilProton Pump InhibitorsEfflux Pump InhibitorsMycobacterial Efflux PumpsTuberculosis Rifampicin ToleranceMacrophagesAntitubercular AgentsMycobacterium tuberculosisDrug ToleranceMicrobial Sensitivity TestsBiological SciencesBacterial ProteinsHumansTuberculosisRifampintuberculosis rifampicin tolerance, mycobacterial efflux pumps, efflux pump inhibitors, proton pump inhibitors, verapamil

Sustainable Development Goals

SDG 3: 3. Good health

The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance

FAIR Checklist

Authors (12)

Funding (11 grants)

Open Access

Topics

Annotations (Europe PMC)